VANGARD LABS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 12 Jan 2026)
What this means for you
Registered since 07 Jan 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88222580
- Registration number
- 5953098
- Mark type
- Stylized text
- Filed
- 10 Dec 2018
- Published for opposition
- 22 Oct 2019
- Registered
- 07 Jan 2020
- Attorney of record
- Erich G. Rhynhart
Goods and services
- Class 005 — Pharmaceuticals: Prescription pharmaceuticals and non-prescription pharmaceuticals for humans for the treatment of cardiac disorders, cerebral disorder, psychiatric and mental health disorders, hepatic system disorders, pain management, gastrointestinal disorders, dietary supplementation, immune system disorders, pancreatic system disorders, urinary system disorders, respiratory system disorders, circulatory system disorders, musculoskeletal disorders, nervous system disorders, inflammatory disorders and mineral supplementation; vitamins; dietary supplements, all of the foregoing excluding canine vaccines
Owner
- NCS Healthcare of Kentucky, Inc., Woonsocket, RI, US
- NCS Healthcare of Kentucky, Inc., Woonsocket, RI, US
- NCS Healthcare of Kentucky, Inc., Woonsocket, RI, US
Prosecution history
- 12 Jan 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 12 Jan 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 05 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 29 Dec 2025 — OFFICE ACTION ISSUED POU1
- 29 Dec 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 25 Nov 2025 — TEAS SECTION 8 & 15 RECEIVED
- 07 Jan 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 07 Jan 2020 — REGISTERED-PRINCIPAL REGISTER
- 22 Oct 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Oct 2019 — PUBLISHED FOR OPPOSITION
- 02 Oct 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Sept 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Sept 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Sept 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 Sept 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED